Heuman R, Sjödahl R, Tagesson C
Acta Chir Scand. 1982;148(3):281-4.
We have investigated the intestinal permeability to polyethyleneglycol (PEG) 1 000 in 25 healthy individuals and 28 patients with Crohn's disease who had undergone ileocolic resection. The intestinal permeability was determined by measuring the 6-hour urinary recovery after oral intake of 10 g PEG 1 000. The patients with Crohn's disease excreted significantly less (p less than 0.001) PEG 1 000 than the healthy individuals (33.7 +/- 16.0 per thousand of the ingested dose vs. 48.6 +/- 15.5 per thousand). There was a correlation between the urinary output and the length of ileal resection, but no difference in output between patients with and without recurrent disease or episodic arthralgia. These findings indicate that, although the gut is considerably permeable to larger, polar molecules, and permeability to PEG 1 000 in Crohn's disease is not increased over that in healthy individuals and appears unrelated to the presence of recurrence and arthralgia.
我们研究了25名健康个体以及28例接受回结肠切除术的克罗恩病患者对聚乙二醇(PEG)1000的肠道通透性。通过测量口服10克PEG 1000后6小时的尿液回收率来确定肠道通透性。克罗恩病患者排出的PEG 1000明显少于健康个体(分别为摄入剂量的千分之33.7±16.0和千分之48.6±15.5,p<0.001)。尿量与回肠切除长度之间存在相关性,但复发疾病或发作性关节痛患者与无这些情况的患者之间尿量无差异。这些发现表明,尽管肠道对较大的极性分子具有相当的通透性,且克罗恩病患者对PEG 1000的通透性并不高于健康个体,且似乎与复发和关节痛的存在无关。